Shifting indications can accelerate a medical devices’ original intention
The BOTLab team entered GCMI’s Accelerator program with a promising technology, clinical need and prototype. Dr. Darren Roblyer shared with us why the team is making this strategic course correction, learnings from BOTLabs’ time in GCMI’s Accelerator program and next steps.